Assignee
KORANEX CAPITAL
CA·3 granted patents·4 pending applications·5 citations·filing 2019–2024
Top patents by PatentIndex Score
7 records- 0186US10973910B1Neoglycoconjugates as vaccines and therapeutic toolsKORANEX CAPITAL·Filed 2020·Granted Apr 13, 2021·2 cites·20 claims
- 0283US10610576B2Precision glycoconjugates as therapeutic toolsKORANEX CAPITAL·Filed 2019·Granted Apr 7, 2020·3 cites·20 claims
- 0373US2024216491A1Neoglycoconjugates as vaccines and therapeutic toolsKORANEX CAPITAL·Filed 2024·Application pending·0 cites
- 0464US11925680B2Neoglycoconjugates as vaccines and therapeutic toolsKORANEX CAPITAL·Filed 2020·Granted Mar 12, 2024·0 cites·14 claims
- 0556US2025134812A1Synthetic glycolipids and glycoliposome compositions : suitable for cargo delivery to the central nervous systemKORANEX CAPITAL·Filed 2022·Application pending·0 cites
- 0654US2024308991A1Process for the synthesis of reactive carbohydrates including antigen precursors for conjugation with a carrier materialKORANEX CAPITAL·Filed 2022·Application pending·0 cites
- 0752US2020261560A1Precision glycoconjugates as therapeutic toolsKORANEX CAPITAL·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when KORANEX CAPITAL files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →